Pub Date : 2025-11-27eCollection Date: 2025-11-01DOI: 10.1093/phe/phaf023
Lovro Savić
According to the Public Goods Account, proposed by Jonny Anomaly, public health activities should only be concerned with the provision of health-related public goods. In this paper, I argue that the Public Goods Account cannot serve as an adequate account of public health activity. The main reason is that its central concept, that of health-related public goods, is itself implausible. I offer two potential understandings of health-related public goods and argue that, on both understandings, the provision of health-related public goods is neither necessary nor sufficient for a public health activity. First, on both understandings, there are plausible examples of public health activities that do not produce health-related public goods. And second, there are examples of non-public health activities that produce health-related public goods.
{"title":"Why Public Health Is Not About Public Goods.","authors":"Lovro Savić","doi":"10.1093/phe/phaf023","DOIUrl":"10.1093/phe/phaf023","url":null,"abstract":"<p><p>According to the <i>Public Goods Account</i>, proposed by Jonny Anomaly, public health activities should only be concerned with the provision of <i>health-related</i> public goods. In this paper, I argue that the <i>Public Goods Account</i> cannot serve as an adequate account of public health activity. The main reason is that its central concept, that of health-related public goods, is itself implausible. I offer two potential understandings of health-related public goods and argue that, on both understandings, the provision of health-related public goods is neither necessary nor sufficient for a public health activity. First, on both understandings, there are plausible examples of public health activities that do not produce health-related public goods. And second, there are examples of non-public health activities that produce health-related public goods.</p>","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"18 3","pages":"phaf023"},"PeriodicalIF":2.0,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12659739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145649915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-14eCollection Date: 2025-11-01DOI: 10.1093/phe/phaf021
Cal Paterson
Obesity is a complex chronic illness of adiposity, yet body weight and obesity are routinely conflated in public health wording and policy design. This paper examines a recent recommendation from the Australian College of Nursing (ACN) to combat obesity via the routine collection and discussion of weight and height data of all school-aged children in the country. The obesity-specific ethical framework developed by ten Have and colleagues (2013) has been used to critique the ACN proposal, and to propose a shift away from weighing people, particularly young people, in health promotion activities for obesity.
{"title":"Should Weight be Given Less Weight in Public Health?","authors":"Cal Paterson","doi":"10.1093/phe/phaf021","DOIUrl":"10.1093/phe/phaf021","url":null,"abstract":"<p><p>Obesity is a complex chronic illness of adiposity, yet body weight and obesity are routinely conflated in public health wording and policy design. This paper examines a recent recommendation from the Australian College of Nursing (ACN) to combat obesity via the routine collection and discussion of weight and height data of all school-aged children in the country. The obesity-specific ethical framework developed by ten Have and colleagues (2013) has been used to critique the ACN proposal, and to propose a shift away from weighing people, particularly young people, in health promotion activities for obesity.</p>","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"18 3","pages":"phaf021"},"PeriodicalIF":2.0,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12617346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145543643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01eCollection Date: 2025-11-01DOI: 10.1093/phe/phaf014
Anand Sergeant
In light of the COVID-19 pandemic, global health organizations have called for the implementation of robust global disease surveillance systems to recognize and respond to emerging pathogens. These active surveillance technologies would have a significant global benefit by preventing the spread of current pandemics and informing future pandemic responses. In this paper, I examine the extent to which we can sacrifice individuals' privacy through global disease surveillance in order to benefit current and future generations. First, I outline disease surveillance technologies and explain how disease surveillance would occur primarily in low-income, rural communities in the Global South. Next, I outline privacy-related harms that these individuals would experience as a result of disease surveillance. I argue that within our current distributional system for global health resources, pandemic surveillance would impose privacy-related burdens on marginalized communities, who would receive inadequate benefits from these programs. This is unfair because it exploits the worst off in order to benefit individuals in wealthy nations. I conclude that to justifiably implement global disease surveillance, we ought to adopt a 'prioritarian' approach to health distribution. To impose privacy-related burdens on the worst off, we must ensure that they benefit significantly.
{"title":"Privacy, Exploitation and Global Disease Surveillance: Can We Justly Prevent the Next Pandemic?","authors":"Anand Sergeant","doi":"10.1093/phe/phaf014","DOIUrl":"10.1093/phe/phaf014","url":null,"abstract":"<p><p>In light of the COVID-19 pandemic, global health organizations have called for the implementation of robust global disease surveillance systems to recognize and respond to emerging pathogens. These active surveillance technologies would have a significant global benefit by preventing the spread of current pandemics and informing future pandemic responses. In this paper, I examine the extent to which we can sacrifice individuals' privacy through global disease surveillance in order to benefit current and future generations. First, I outline disease surveillance technologies and explain how disease surveillance would occur primarily in low-income, rural communities in the Global South. Next, I outline privacy-related harms that these individuals would experience as a result of disease surveillance. I argue that within our current distributional system for global health resources, pandemic surveillance would impose privacy-related burdens on marginalized communities, who would receive inadequate benefits from these programs. This is unfair because it exploits the worst off in order to benefit individuals in wealthy nations. I conclude that to justifiably implement global disease surveillance, we ought to adopt a 'prioritarian' approach to health distribution. To impose privacy-related burdens on the worst off, we must ensure that they benefit significantly.</p>","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"18 3","pages":"phaf014"},"PeriodicalIF":2.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12400026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144994150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-10eCollection Date: 2025-07-01DOI: 10.1093/phe/phaf007
Alvin Chen
Public health is commonly regarded as a branch of public policy. While few governments would dispute that public health should be a core responsibility of the state, in practice, it is frequently reduced to a branch of administration, in competition with other branches over annual budget distributions and policy priority. This paper advances the argument that the state should prioritize public health for one crucial reason: public health is a normative principle that constitutes the modern state. As a constitutional principle, it demands the state to promote and preserve public health. The paper examines first what makes public health a normative principle, and then examines why it is a normative principle that makes demands on the state. In so doing, the paper distinguishes public health as a constitutional principle from the constitutional right to health. The paper concludes with a reflection on the urgency to prioritize public health, not merely because of policy needs, but on the ground that it is a foundational normative principle of the modern state.
{"title":"Public Health as a Constitutional Principle.","authors":"Alvin Chen","doi":"10.1093/phe/phaf007","DOIUrl":"10.1093/phe/phaf007","url":null,"abstract":"<p><p>Public health is commonly regarded as a branch of public policy. While few governments would dispute that public health should be a core responsibility of the state, in practice, it is frequently reduced to a branch of administration, in competition with other branches over annual budget distributions and policy priority. This paper advances the argument that the state should prioritize public health for one crucial reason: public health is a normative principle that constitutes the modern state. As a constitutional principle, it demands the state to promote and preserve public health. The paper examines first what makes public health a normative principle, and then examines why it is a normative principle that makes demands on the state. In so doing, the paper distinguishes public health as a constitutional principle from the constitutional right to health. The paper concludes with a reflection on the urgency to prioritize public health, not merely because of policy needs, but on the ground that it is a foundational normative principle of the modern state.</p>","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"18 2","pages":"phaf007"},"PeriodicalIF":1.4,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12242155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144610138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-14eCollection Date: 2024-11-01DOI: 10.1093/phe/phae009
Stuart Rennie, Sara Levintow, Adam Gilbertson, Winnie Kavulani Luseno
Mathematical modelling has played an increasingly prominent role in public health responses, for example by offering estimates of how infectious disease incidence over time may be affected by the adoption of certain policies and interventions. In this paper, we call for greater research and reflection into the ethics of mathematical modeling in public health. First, we present some promising ways of framing the ethics of mathematical modeling that have been offered in the very few publications specifically devoted to this subject. Second, to draw out some issues that have not yet been sufficiently considered, we bring in the case of mathematical modeling in voluntary medical male circumcision (VMMC) initiatives for HIV prevention in Africa. We argue that greater attention should be paid to ethical considerations in mathematical modeling, particularly as its use is becoming more widespread and its potential impacts are becoming greater in the 'big data' era, as witnessed during the COVID-19 pandemic.
{"title":"Ethics of Mathematical Modeling in Public Health: The Case of Medical Male Circumcision for HIV Prevention in Africa.","authors":"Stuart Rennie, Sara Levintow, Adam Gilbertson, Winnie Kavulani Luseno","doi":"10.1093/phe/phae009","DOIUrl":"10.1093/phe/phae009","url":null,"abstract":"<p><p>Mathematical modelling has played an increasingly prominent role in public health responses, for example by offering estimates of how infectious disease incidence over time may be affected by the adoption of certain policies and interventions. In this paper, we call for greater research and reflection into the ethics of mathematical modeling in public health. First, we present some promising ways of framing the ethics of mathematical modeling that have been offered in the very few publications specifically devoted to this subject. Second, to draw out some issues that have not yet been sufficiently considered, we bring in the case of mathematical modeling in voluntary medical male circumcision (VMMC) initiatives for HIV prevention in Africa. We argue that greater attention should be paid to ethical considerations in mathematical modeling, particularly as its use is becoming more widespread and its potential impacts are becoming greater in the 'big data' era, as witnessed during the COVID-19 pandemic.</p>","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"17 3","pages":"125-138"},"PeriodicalIF":2.0,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11638778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142830639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-29eCollection Date: 2024-11-01DOI: 10.1093/phe/phae008
Manisha Pahwa, Julia Abelson, Paul A Demers, Lisa Schwartz, Katrina Shen, Meredith Vanstone
Normative issues associated with the design and implementation of population-based lung cancer screening policies are underexamined. This study was an exposition of the ethical justification for screening and potential ethical issues and their solutions in Canadian jurisdictions. A qualitative description study was conducted. Key informants, defined as policymakers, scientists and clinicians who develop and implement lung cancer screening policies in Canada, were purposively sampled and interviewed using a semi-structured guide informed by population-based disease screening principles and ethical issues in cancer screening. Interview data were analyzed using qualitative content analysis. Fifteen key informants from seven provinces were interviewed. Virtually all justified screening by beneficence, describing that population benefits outweigh individual harms if high-risk people are screened in organized programs according to disease screening principles. Equity of screening access, stigma and lung cancer primary prevention were other ethical issues identified. Key informants prioritized beneficence over concerns for group-level justice issues when making decisions about whether to implement screening policies. This prioritization, though slight, may impede the implementation of screening policies in a way that effectively addresses justice issues, a goal likely to require justice theory and critical interpretation of disease screening principles.
{"title":"Ethical Dimensions of Population-Based Lung Cancer Screening in Canada: Key Informant Qualitative Description Study.","authors":"Manisha Pahwa, Julia Abelson, Paul A Demers, Lisa Schwartz, Katrina Shen, Meredith Vanstone","doi":"10.1093/phe/phae008","DOIUrl":"10.1093/phe/phae008","url":null,"abstract":"<p><p>Normative issues associated with the design and implementation of population-based lung cancer screening policies are underexamined. This study was an exposition of the ethical justification for screening and potential ethical issues and their solutions in Canadian jurisdictions. A qualitative description study was conducted. Key informants, defined as policymakers, scientists and clinicians who develop and implement lung cancer screening policies in Canada, were purposively sampled and interviewed using a semi-structured guide informed by population-based disease screening principles and ethical issues in cancer screening. Interview data were analyzed using qualitative content analysis. Fifteen key informants from seven provinces were interviewed. Virtually all justified screening by beneficence, describing that population benefits outweigh individual harms if high-risk people are screened in organized programs according to disease screening principles. Equity of screening access, stigma and lung cancer primary prevention were other ethical issues identified. Key informants prioritized beneficence over concerns for group-level justice issues when making decisions about whether to implement screening policies. This prioritization, though slight, may impede the implementation of screening policies in a way that effectively addresses justice issues, a goal likely to require justice theory and critical interpretation of disease screening principles.</p>","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"17 3","pages":"139-153"},"PeriodicalIF":1.4,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11637757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142830636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Life with chronic disease and chronic care is hard and people who live in disadvantage may lack the freedom to prioritise their care because of increased competing demands. This paper proposes that shifting the goals of chronic care from self-management support to a shared-management approach can help improve wellbeing and health outcomes across social groups. This work draws on a qualitative exploration of the lived experience of chronic disease and an applied ethical analysis of the reproduction of disadvantages within chronic care. The qualitative results further specify respectful and collaborative patient-healthcare professional relationships; autonomy-supportive interventions; and continuity of care to face the complexity of chronicity in a phenomenological sense—a paradoxical experience of long duration that comprises the disease’s presence in the absence of its manifestation. The ethical analysis draws on performativity; autonomy and decision-making; and responsibility, which constitute the theoretical foundation for shared-management. This approach contributes to advance current normative thinking for health justice and outlines practical steps for its clinical implementation in the delivery of chronic care.
{"title":"From Self-Management to Shared-Management: A Relational Approach for Equitable Chronic Care","authors":"Francisca Stutzin Donoso","doi":"10.1093/phe/phae007","DOIUrl":"https://doi.org/10.1093/phe/phae007","url":null,"abstract":"Life with chronic disease and chronic care is hard and people who live in disadvantage may lack the freedom to prioritise their care because of increased competing demands. This paper proposes that shifting the goals of chronic care from self-management support to a shared-management approach can help improve wellbeing and health outcomes across social groups. This work draws on a qualitative exploration of the lived experience of chronic disease and an applied ethical analysis of the reproduction of disadvantages within chronic care. The qualitative results further specify respectful and collaborative patient-healthcare professional relationships; autonomy-supportive interventions; and continuity of care to face the complexity of chronicity in a phenomenological sense—a paradoxical experience of long duration that comprises the disease’s presence in the absence of its manifestation. The ethical analysis draws on performativity; autonomy and decision-making; and responsibility, which constitute the theoretical foundation for shared-management. This approach contributes to advance current normative thinking for health justice and outlines practical steps for its clinical implementation in the delivery of chronic care.","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"24 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142205073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Freya Saich, Shelley Walker, Margaret Hellard, Mark Stoové, Kate Seear
Hepatitis C is a global public health threat, affecting 56 million people worldwide. The World Health Organization has committed to eliminating hepatitis C by 2030. Although new treatments have revolutionised the treatment and care of people with hepatitis C, treatment uptake has slowed in recent years, drawing attention to the need for innovative approaches to reach elimination targets. One approach involves using existing notifiable disease data to contact people previously diagnosed with hepatitis C. Within these disease surveillance systems, however, competing tensions exist, including protecting individual rights to privacy and autonomy, and broader public health goals. We explore these issues using hepatitis C and Australia’s legislative and regulatory frameworks as a case study. We examine emerging uses of notification data to contact people not yet treated, and describe some of the ethical dilemmas associated with the use and non-use of this data and the protections that exist to preserve individual rights and public health. We reveal weaknesses in rights protections and processes under Australian public health and human rights legislation and argue for consultation with and involvement of affected communities in policy and intervention design before notification data is used to increase hepatitis C treatment coverage.
{"title":"The Application of Australian Rights Protections to the Use of Hepatitis C Notification Data to Engage People ‘Lost to Follow Up’","authors":"Freya Saich, Shelley Walker, Margaret Hellard, Mark Stoové, Kate Seear","doi":"10.1093/phe/phae006","DOIUrl":"https://doi.org/10.1093/phe/phae006","url":null,"abstract":"Hepatitis C is a global public health threat, affecting 56 million people worldwide. The World Health Organization has committed to eliminating hepatitis C by 2030. Although new treatments have revolutionised the treatment and care of people with hepatitis C, treatment uptake has slowed in recent years, drawing attention to the need for innovative approaches to reach elimination targets. One approach involves using existing notifiable disease data to contact people previously diagnosed with hepatitis C. Within these disease surveillance systems, however, competing tensions exist, including protecting individual rights to privacy and autonomy, and broader public health goals. We explore these issues using hepatitis C and Australia’s legislative and regulatory frameworks as a case study. We examine emerging uses of notification data to contact people not yet treated, and describe some of the ethical dilemmas associated with the use and non-use of this data and the protections that exist to preserve individual rights and public health. We reveal weaknesses in rights protections and processes under Australian public health and human rights legislation and argue for consultation with and involvement of affected communities in policy and intervention design before notification data is used to increase hepatitis C treatment coverage.","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"210 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141063381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-23eCollection Date: 2024-04-01DOI: 10.1093/phe/phad022
Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski
{"title":"Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency.","authors":"Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski","doi":"10.1093/phe/phad022","DOIUrl":"10.1093/phe/phad022","url":null,"abstract":"","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"17 1-2","pages":"1-4"},"PeriodicalIF":1.4,"publicationDate":"2024-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141617478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The nascent for-profit psychedelic industry has begun to engage in corporate practices like funding scientific research and research programs. There is substantial evidence that such practices from other industries like tobacco, alcohol, pharmaceuticals and food create conflicts of interest and can negatively influence population health. However, in a context of funding pressures, low publicly funded success rates and precarious academic labor, there is limited ethics guidance for researchers working at the intersection of clinical practice and population health as to how they should approach potential financial sponsorship from for-profit entities, such as the psychedelic industry. This article reports on a reflective exercise among a group of clinician scientists working in psychedelic science, where we applied Adams’ (2016) PERIL (Purpose, Extent, Relevant harm, Identifiers, Link) ethical decision-making framework to a fictionalized case of corporate psychedelic financial sponsorship. Our analysis suggests financial relationships with the corporate psychedelic sector may create varying degrees of risk to a research program’s purpose, autonomy and integrity. We argue that the commercial determinants of health provide a useful framework for understanding the ethics of industry-healthcare entanglements and can provide an important population health ethics lens to examine nascent industries such as psychedelics, and work toward potential solutions.
{"title":"Psychedelics in PERIL: The Commercial Determinants of Health, Financial Entanglements and Population Health Ethics","authors":"Daniel Buchman, Daniel Rosenbaum","doi":"10.1093/phe/phae002","DOIUrl":"https://doi.org/10.1093/phe/phae002","url":null,"abstract":"The nascent for-profit psychedelic industry has begun to engage in corporate practices like funding scientific research and research programs. There is substantial evidence that such practices from other industries like tobacco, alcohol, pharmaceuticals and food create conflicts of interest and can negatively influence population health. However, in a context of funding pressures, low publicly funded success rates and precarious academic labor, there is limited ethics guidance for researchers working at the intersection of clinical practice and population health as to how they should approach potential financial sponsorship from for-profit entities, such as the psychedelic industry. This article reports on a reflective exercise among a group of clinician scientists working in psychedelic science, where we applied Adams’ (2016) PERIL (Purpose, Extent, Relevant harm, Identifiers, Link) ethical decision-making framework to a fictionalized case of corporate psychedelic financial sponsorship. Our analysis suggests financial relationships with the corporate psychedelic sector may create varying degrees of risk to a research program’s purpose, autonomy and integrity. We argue that the commercial determinants of health provide a useful framework for understanding the ethics of industry-healthcare entanglements and can provide an important population health ethics lens to examine nascent industries such as psychedelics, and work toward potential solutions.","PeriodicalId":49136,"journal":{"name":"Public Health Ethics","volume":"20 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140017119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}